Alan Hibbard, Precious Metals and Alternative Money Specialist at GoldSilver.com, discusses the rising significance of gold as a safe haven, projecting prices may soar beyond $3,000 per ounce by 2025, while contrasting it with Bitcoin's challenges as a transactional currency. Madison Muller, Bloomberg News Health Reporter, dives into the healthcare sector's future, highlighting the impact of emerging weight loss drugs and potential market challenges, including accessibility and competition driven by telehealth innovations.

In this discussion, Madison Muller, a Bloomberg reporter specializing in pharmaceuticals, explores the explosive growth of weight-loss drugs like Ozempic and Wegovy through telehealth. She highlights the dangers of easy access to these medications, particularly for those recovering from eating disorders. Personal accounts reveal the allure and risks of appetite suppressants, stressing the need for responsible prescribing practices. Muller's insights shine a light on the critical balance between accessibility and patient safety in the weight-loss drug market.

Madison Muller, a Bloomberg News health reporter, delves into activist investor Starboard Value's $1 billion stake in Pfizer, revealing the company's struggles post-COVID. Katie Thomas analyzes consumer spending trends, especially for Halloween. Dr. Ellen Wald discusses the impact of Middle Eastern tensions on oil prices, while Teri Williams highlights the economic progress of Black women in promoting inclusivity. Jamie Battmer offers insights on today's investment landscape amidst these challenges.

In this engaging discussion, Bloomberg News Reporter Tyler Kendall chats with Nvidia CEO Jensen Huang about rising tensions between Nvidia and China, urging local companies to shift away from the tech giant. Senior Tech Analyst Mandeep Singh shares insights on Arm's challenges with Intel amidst geopolitical pressures. Rich Lesser emphasizes urgent climate strategies from NYC Climate Week, while health expert Iman Abuzeid highlights new initiatives for nurses ahead of the 2024 elections, addressing workforce safety and support. A thought-provoking blend of tech and health!

Madison Muller, a Bloomberg News Health Care Reporter, dives into Eli Lilly's innovative strategy of selling its weight-loss drug Zepbound in self-fill vials at a budget-friendly $399 monthly. Silvio Tavares, CEO of VantageScore, sheds light on the latest credit data trends and consumer behaviors. Bret Begun, Senior Editor at Bloomberg Businessweek, discusses the explosive rise of sports betting in America and its implications for the industry and state revenues. Tune in for insights on health, finance, and the evolving media landscape.

Madison Muller, a Bloomberg News Health Care Reporter, dives into groundbreaking research revealing that Eli Lilly's ZEP Bound can reduce diabetes risk by 94% in obese patients over three years. She discusses the significant long-term health benefits of weight-loss drugs and their role in battling chronic diseases like type 2 diabetes. The conversation also covers the shift from injections to pills in drug delivery and the fierce competition among pharmaceutical firms driving these innovations.

Madison Muller, a health reporter, reveals how Ozempic has dramatically transformed a small town's health landscape, triggering discussions on its market impact. Kevin Near delves into Warner Bros' financial struggles amidst media industry shifts, while Greg Petro highlights social media's power in shaping consumer choices, revealing inherent biases. Jayson Bronchetti discusses financial market dynamics, particularly in relation to jobless claims and consumer behavior trends, offering insights on long-term investment strategies and their implications for economic health.

Bryan Whalen, Chief Investment Officer at TCW, shares insights on market trends and volatility. Claudia Sahm, Chief Economist at New Century Advisors, discusses her unorthodox view on recession indicators. Madison Muller, Bloomberg Health Reporter, reveals the latest on Eli Lilly's weight loss drugs and market competition. Poonam Goyal, Senior Analyst at Bloomberg, analyzes Under Armour's earnings and the brand's struggle against larger competitors. The conversation dives deep into investment strategies amidst shifting economic data.

In this insightful discussion, Madison Muller, a Bloomberg healthcare reporter, dives into the transformative impacts of weight-loss drugs like Ozempic in Bowling Green, Kentucky. She uncovers personal stories of locals experiencing profound changes and explores the city's high obesity rates and supportive healthcare policies. The ripple effects on local businesses and the emergence of a thriving side economy are also discussed, highlighting challenges related to affordability and accessibility. It's a fascinating look at how medication can reshape a community.

Bloomberg News Anchor reports on ConocoPhillips acquiring Marathon Oil for $17 billion. Ro CEO discusses weight-loss drug shortages and telehealth innovation. Businessweek story on Dave & Buster's turning arcades into casinos. JLL's CEO talks about Fed policy impact on commercial real estate. Alex McGrath wraps up the episode with insights on market trends and investments.